Immunovant will not pursue further development of IMVT-1402 for skin lupus after a trial missed its main goal, despite some ...

Too many with lupus are stuck in the gap between being too sick to work, but not sick enough for disability, says columnist ...

Severe flare-ups of systemic lupus erythematosus (SLE) among patients were associated with a markedly higher risk of stroke, according to the results of a population-based study in Taiwan that ...

Marisa Zeppieri is a journalist, author of two books, and former Mrs. New York 2015. Her verticals include health, nutrition, food, recipe creation, and food photography. She is also the founder of ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Seattle Children’s has been cleared by the U.S. Food and Drug ...

Where were you when you were told you had lupus? Who gave you the official diagnosis? Confirming lupus is a challenge, not only because it seems to be a mystery to primary care physicians and ...

Brepocitinib, an investigational oral therapy, failed to show any benefits beyond a placebo in a Phase 2 clinical trial that tested it in adults with moderate to severely active systemic lupus ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Even though I know the characters with lupus are fictional, I’m filled with empathy and a little ...

A Phase 2b clinical trial of ESK-001, an oral treatment for systemic lupus erythematosus (SLE), has begun dosing patients, according to its developer Alumis. The trial, called LUMUS, is expected to ...

Treatment with Benlysta (belimumab) can help people with lupus avoid disease flares and reduce their need for glucocorticoids, according to new analyses of clinical trial data announced by the therapy ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The National Institute of Diabetes and Digestive and Kidney ...

Ventus Therapeutics plans to develop a new treatment candidate for lupus and other inflammatory diseases marked by the activation of the type 1 interferon immune system pathway, the company recently ...